Additional Information

Md Masud Alam, Ph.D., has an extensive background in developing adjuvant-based immunotherapies for solid tumors, as well as studying alarmin-induced activation of immune cells and their induction of inflammatory damage in the nervous system. He uses comparative genomics, proteomics, and molecular and cellular biology to describe the role of natural killer T (NKT) cells during brain tumor development, which may help to develop more effective therapies.